Gut homing molecule regulation of the pathogenesis and treatment of inflammatory bowel diseases

Heather L. Evans-Marin, Yingzi Cong

Research output: Contribution to journalArticle

Abstract

Inflammatory bowel disease is a chronic, debilitating immunological disorder for which there are few effective treatments. New therapies targeting gut homing molecules, such as CCR9 and α4β7, are currently in development, with some of these reaching clinical trials. Gut-trophic molecules and their receptors are critical to the development of both tolerant and inflammatory immune responses in the gut. However, we know little regarding the function of homing molecules as it relates to IBD. Data have suggested both pathological and protective roles for gut homing molecules in IBD development and maintenance. In addition, recent research findings have suggested that chemokines can influence T cell differentiation and function. Given the current clinical relevance, it is essential to obtain a better understanding of the role of gut homing molecules in the regulation of IBD.

Original languageEnglish (US)
Pages (from-to)4-12
Number of pages9
JournalInflammation and Allergy - Drug Targets
Volume14
Issue number1
StatePublished - Dec 1 2015

Fingerprint

Inflammatory Bowel Diseases
Chemokines
Cell Differentiation
Maintenance
Clinical Trials
T-Lymphocytes
Research
Therapeutics

Keywords

  • CCR9
  • Chemokine
  • IBD
  • Inflammation
  • Intestines
  • T cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Gut homing molecule regulation of the pathogenesis and treatment of inflammatory bowel diseases. / Evans-Marin, Heather L.; Cong, Yingzi.

In: Inflammation and Allergy - Drug Targets, Vol. 14, No. 1, 01.12.2015, p. 4-12.

Research output: Contribution to journalArticle

@article{53feefb89b1a455c99cd96a8a80ba835,
title = "Gut homing molecule regulation of the pathogenesis and treatment of inflammatory bowel diseases",
abstract = "Inflammatory bowel disease is a chronic, debilitating immunological disorder for which there are few effective treatments. New therapies targeting gut homing molecules, such as CCR9 and α4β7, are currently in development, with some of these reaching clinical trials. Gut-trophic molecules and their receptors are critical to the development of both tolerant and inflammatory immune responses in the gut. However, we know little regarding the function of homing molecules as it relates to IBD. Data have suggested both pathological and protective roles for gut homing molecules in IBD development and maintenance. In addition, recent research findings have suggested that chemokines can influence T cell differentiation and function. Given the current clinical relevance, it is essential to obtain a better understanding of the role of gut homing molecules in the regulation of IBD.",
keywords = "CCR9, Chemokine, IBD, Inflammation, Intestines, T cells",
author = "Evans-Marin, {Heather L.} and Yingzi Cong",
year = "2015",
month = "12",
day = "1",
language = "English (US)",
volume = "14",
pages = "4--12",
journal = "Current Drug Targets: Inflammation and Allergy",
issn = "1871-5281",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Gut homing molecule regulation of the pathogenesis and treatment of inflammatory bowel diseases

AU - Evans-Marin, Heather L.

AU - Cong, Yingzi

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Inflammatory bowel disease is a chronic, debilitating immunological disorder for which there are few effective treatments. New therapies targeting gut homing molecules, such as CCR9 and α4β7, are currently in development, with some of these reaching clinical trials. Gut-trophic molecules and their receptors are critical to the development of both tolerant and inflammatory immune responses in the gut. However, we know little regarding the function of homing molecules as it relates to IBD. Data have suggested both pathological and protective roles for gut homing molecules in IBD development and maintenance. In addition, recent research findings have suggested that chemokines can influence T cell differentiation and function. Given the current clinical relevance, it is essential to obtain a better understanding of the role of gut homing molecules in the regulation of IBD.

AB - Inflammatory bowel disease is a chronic, debilitating immunological disorder for which there are few effective treatments. New therapies targeting gut homing molecules, such as CCR9 and α4β7, are currently in development, with some of these reaching clinical trials. Gut-trophic molecules and their receptors are critical to the development of both tolerant and inflammatory immune responses in the gut. However, we know little regarding the function of homing molecules as it relates to IBD. Data have suggested both pathological and protective roles for gut homing molecules in IBD development and maintenance. In addition, recent research findings have suggested that chemokines can influence T cell differentiation and function. Given the current clinical relevance, it is essential to obtain a better understanding of the role of gut homing molecules in the regulation of IBD.

KW - CCR9

KW - Chemokine

KW - IBD

KW - Inflammation

KW - Intestines

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=84953379841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953379841&partnerID=8YFLogxK

M3 - Article

C2 - 26296210

AN - SCOPUS:84953379841

VL - 14

SP - 4

EP - 12

JO - Current Drug Targets: Inflammation and Allergy

JF - Current Drug Targets: Inflammation and Allergy

SN - 1871-5281

IS - 1

ER -